Literature DB >> 24022427

A glioblastoma neurosphere line with alternative lengthening of telomeres.

Christopher M Heaphy, Karisa C Schreck, Eric Raabe, Xing Gang Mao, Ping An, Qian Chu, Weijie Poh, Yuchen Jiao, Fausto J Rodriguez, Yazmin Odia, Alan K Meeker, Charles G Eberhart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24022427      PMCID： PMC3874856          DOI： 10.1007/s00401-013-1174-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  10 in total

1.  Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival.

Authors:  Kerrie L McDonald; Julie McDonnell; Alessandra Muntoni; Jeremy D Henson; Monika E Hegi; Andreas von Deimling; Helen R Wheeler; Ray J Cook; Michael T Biggs; Nicholas S Little; Bruce G Robinson; Roger R Reddel; Janice A Royds
Journal:  J Neuropathol Exp Neurol       Date:  2010-07       Impact factor: 3.685

2.  Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.

Authors:  Christopher M Heaphy; Andrea P Subhawong; Seung-Mo Hong; Michael G Goggins; Elizabeth A Montgomery; Edward Gabrielson; George J Netto; Jonathan I Epstein; Tamara L Lotan; William H Westra; Ie-Ming Shih; Christine A Iacobuzio-Donahue; Anirban Maitra; Qing K Li; Charles G Eberhart; Janis M Taube; Dinesh Rakheja; Robert J Kurman; T C Wu; Richard B Roden; Pedram Argani; Angelo M De Marzo; Luigi Terracciano; Michael Torbenson; Alan K Meeker
Journal:  Am J Pathol       Date:  2011-09-01       Impact factor: 4.307

3.  Alternative lengthening of telomeres in human glioma stem cells.

Authors:  David C Silvestre; José R Pineda; Françoise Hoffschir; Jeanne-Marie Studler; Marc-André Mouthon; Françoise Pflumio; Marie-Pierre Junier; Hervé Chneiweiss; François D Boussin
Journal:  Stem Cells       Date:  2011-03       Impact factor: 6.277

4.  Altered telomeres in tumors with ATRX and DAXX mutations.

Authors:  Christopher M Heaphy; Roeland F de Wilde; Yuchen Jiao; Alison P Klein; Barish H Edil; Chanjuan Shi; Chetan Bettegowda; Fausto J Rodriguez; Charles G Eberhart; Sachidanand Hebbar; G Johan Offerhaus; Roger McLendon; B Ahmed Rasheed; Yiping He; Hai Yan; Darell D Bigner; Sueli Mieko Oba-Shinjo; Suely Kazue Nagahashi Marie; Gregory J Riggins; Kenneth W Kinzler; Bert Vogelstein; Ralph H Hruban; Anirban Maitra; Nickolas Papadopoulos; Alan K Meeker
Journal:  Science       Date:  2011-06-30       Impact factor: 47.728

5.  Mutation analysis of candidate genes within the 2q33.3 linkage area for familial early-onset generalised osteoarthritis.

Authors:  Josine L Min; Ingrid Meulenbelt; Margreet Kloppenburg; Cornelia M van Duijn; P Eline Slagboom
Journal:  Eur J Hum Genet       Date:  2007-04-04       Impact factor: 4.246

6.  The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance.

Authors:  Karisa C Schreck; Pete Taylor; Luigi Marchionni; Vidya Gopalakrishnan; Eli E Bar; Nicholas Gaiano; Charles G Eberhart
Journal:  Clin Cancer Res       Date:  2010-12-15       Impact factor: 12.531

7.  Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas.

Authors:  Doreen N Nguyen; Christopher M Heaphy; Roeland F de Wilde; Brent A Orr; Yazmin Odia; Charles G Eberhart; Alan K Meeker; Fausto J Rodriguez
Journal:  Brain Pathol       Date:  2012-09-24       Impact factor: 6.508

8.  Telomere elongation in immortal human cells without detectable telomerase activity.

Authors:  T M Bryan; A Englezou; J Gupta; S Bacchetti; R R Reddel
Journal:  EMBO J       Date:  1995-09-01       Impact factor: 11.598

9.  Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas.

Authors:  Yuchen Jiao; Patrick J Killela; Zachary J Reitman; Ahmed B Rasheed; Christopher M Heaphy; Roeland F de Wilde; Fausto J Rodriguez; Sergio Rosemberg; Sueli Mieko Oba-Shinjo; Suely Kazue Nagahashi Marie; Chetan Bettegowda; Nishant Agrawal; Eric Lipp; Christopher Pirozzi; Giselle Lopez; Yiping He; Henry Friedman; Allan H Friedman; Gregory J Riggins; Matthias Holdhoff; Peter Burger; Roger McLendon; Darell D Bigner; Bert Vogelstein; Alan K Meeker; Kenneth W Kinzler; Nickolas Papadopoulos; Luis A Diaz; Hai Yan
Journal:  Oncotarget       Date:  2012-07

10.  IDH1 and IDH2 mutations in gliomas.

Authors:  Hai Yan; D Williams Parsons; Genglin Jin; Roger McLendon; B Ahmed Rasheed; Weishi Yuan; Ivan Kos; Ines Batinic-Haberle; Siân Jones; Gregory J Riggins; Henry Friedman; Allan Friedman; David Reardon; James Herndon; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein; Darell D Bigner
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 176.079
  10 in total
  6 in total

1.  Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells.

Authors:  Ulf D Kahlert; Menglin Cheng; Katharina Koch; Luigi Marchionni; Xing Fan; Eric H Raabe; Jarek Maciaczyk; Kristine Glunde; Charles G Eberhart
Journal:  Int J Cancer       Date:  2015-10-13       Impact factor: 7.396

2.  Genetic Inactivation of ATRX Leads to a Decrease in the Amount of Telomeric Cohesin and Level of Telomere Transcription in Human Glioma Cells.

Authors:  Rita Eid; Marie-Véronique Demattei; Harikleia Episkopou; Corinne Augé-Gouillou; Anabelle Decottignies; Nathalie Grandin; Michel Charbonneau
Journal:  Mol Cell Biol       Date:  2015-06-08       Impact factor: 4.272

3.  A model of a patient-derived IDH1 mutant anaplastic astrocytoma with alternative lengthening of telomeres.

Authors:  Alexandra Borodovsky; Alan K Meeker; Ewen F Kirkness; Qi Zhao; Charles G Eberhart; Gary L Gallia; Gregory J Riggins
Journal:  J Neurooncol       Date:  2014-12-04       Impact factor: 4.130

4.  Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells.

Authors:  Ulf D Kahlert; Abigail K Suwala; Katharina Koch; Manabu Natsumeda; Brent A Orr; Masanori Hayashi; Jarek Maciaczyk; Charles G Eberhart
Journal:  J Neuropathol Exp Neurol       Date:  2015-09       Impact factor: 3.685

5.  Identification of patient-derived glioblastoma stem cell (GSC) lines with the alternative lengthening of telomeres phenotype.

Authors:  Ahsan Farooqi; Jie Yang; Vladislav Sharin; Ravesanker Ezhilarasan; Carla Danussi; Christian Alvarez; Sharvari Dharmaiah; David Irvin; Jason Huse; Erik P Sulman
Journal:  Acta Neuropathol Commun       Date:  2019-05-16       Impact factor: 7.801

6.  A preclinical mouse model of glioma with an alternative mechanism of telomere maintenance (ALT).

Authors:  Maya Jeitany; Jose Ramon Pineda; Qingyuan Liu; Rosa Maria Porreca; Françoise Hoffschir; Chantal Desmaze; David C Silvestre; Patrick Mailliet; Marie-Pierre Junier; Arturo Londoño-Vallejo; Evelyne Ségal-Bendirdjian; Hervé Chneiweiss; François D Boussin
Journal:  Int J Cancer       Date:  2014-09-11       Impact factor: 7.396
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.